Day: September 25, 2025
MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) strongly refutes the misleading and inaccurate claims contained in the short-seller report.
The report contains numerous inaccuracies and mischaracterizations, including about Aya’s current management team, operations, and resource base, which the Corporation believes are intentionally misleading and are intended to benefit the short seller, which has itself disclosed that it stands to profit in the event that the Corporation’s share price declines, at the expense of Aya shareholders.
Key Facts
Reliability of Resource Model Confirmed by Silver Ounces Mined since 2021Since 2020, Aya has produced over 10 million ounces (“Moz”) of silver (“Ag”), with mined ounces consistently reconciling against the published...
NextGen Digital Platforms Inc. Announces Approval of Change of Business
Written by Customer Service on . Posted in Public Companies.
Vancouver, B.C., Sept. 25, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased to announce, further to its news release of September 24, 2025, that the proposed expansion of its business into the digital asset ecosystem and the implementation of a cryptocurrency treasury management strategy (the “Change of Business”) has been approved by a majority of the Company’s shareholders by written consent resolutions. The Company has also received final approval from the Canadian Securities Exchange (the “CSE”) for the Change of Business.
In connection with the Change of Business, the Company has filed a CSE Form 2A – Listing Statement dated September 24, 2025 (the...
Lytus Technologies Holdings PTV. Ltd. Announces 1-for-2,500 Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
Dubai, United Arab Emirates, Sept. 25, 2025 (GLOBE NEWSWIRE) — Lytus Technologies Holdings PTV. Ltd. (OTCQB: LYTHF) (the “Company”), a leader in platform services and next-generation technology, today announced that it intends to effect a reverse stock split of the Company’s common shares at a ratio of 1-for-2,500. The reverse stock split affects all shareholders uniformly and will not alter the relative rights or percentage interest of shareholders in the Company, except as a result of any fractional shares held, as described below.
The Company intends for the reverse stock split to become effective and to begin trading on a split-adjusted basis on the OTCQB at the open of trading on September 26, 2025, under the existing trading symbol “LYTHF”. The new CUSIP number for the common shares following the reverse stock split will...
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Written by Customer Service on . Posted in Public Companies.
Palsonify PillsPalsonify pillsPalsonify LogoPalsonify tabletsCrinetics ExteriorCrinetics headquarters in San Diego, CANovel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly
Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden
Launch of lead product PALSONIFY marks a pivotal milestone for Crinetics as the premier endocrine-focused global pharmaceutical company
Investor call to be held today at 6:00 pm ET
SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) approved PALSONIFYTM...
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
Written by Customer Service on . Posted in Public Companies.
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica’s lens is clinically proven to slow myopia progression in children1,2
Paris, France (25 September 2025) – EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2. The effectiveness of the Essilor Stellest lens is evidenced by clinical data showing that the lens slowed down myopia progression by 71% on average over two years1,2. Leading the global effort to address...
Uniti Group Inc. Announces Pricing of Upsized Senior Notes Offering
Written by Customer Service on . Posted in Public Companies.
Issues Notice of Redemption for Secured Notes due 2028
LITTLE ROCK, Ark., Sept. 25, 2025 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that its subsidiary, Windstream Services, LLC (the “Issuer”), has priced its offering (the “Offering”) of $1.4 billion aggregate principal amount of 7.50% Senior Secured Notes due 2033 (the “Notes”). The offering was upsized by $500.0 million aggregate principal amount compared to the previously announced offering size of $900.0 million. The Notes will be issued at an issue price of 100.00%. The Notes will be guaranteed on a senior unsecured basis by the Company and Uniti Group LLC and on a senior secured basis by each of the Issuer’s subsidiaries that guarantees indebtedness under the Company’s senior secured credit facilities and the Company’s...
G2 Goldfields Closes C$49.5 Million Private Placement
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) is pleased to announce that it has completed the non-brokered private placement announced by the Company on September 11, 2025 (the “Offering”). The Offering consisted of 15,000,000 common shares of the Company (the “Shares”) at a price of C$3.30 per Share, for aggregate gross proceeds of C$49,500,000.
The net proceeds from the Offering are expected to be used for continued exploration and development of the Company’s mineral properties in Guyana and for general working capital and general corporate purposes.
The Shares have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) and may not...
Verizon to be the first carrier to offer the new AI-powered Meta Ray-Ban Display glasses
Written by Customer Service on . Posted in Public Companies.
Revolutionary AI glasses will be available to Verizon customers, offering a new way to stay connected on the go
[Breaking news] BASKING RIDGE, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) — Verizon announced it will be the first wireless carrier to offer the revolutionary new Meta Ray-Ban Display AI glasses, unveiled last week at Meta’s annual Connect conference. This partnership will bring the next generation of wearable AI technology to Verizon customers, offering a seamless experience on the glasses.
The Meta Ray-Ban Display represents a breakthrough in AI glasses, featuring a full-color, high-resolution in-lens display that allows users to stay present in their world while accessing a new suite of AI-powered features. Paired with the innovative Meta Neural Band, the glasses offer intuitive control through subtle hand gestures,...
Organogenesis Provides Update on Second Phase 3 ReNu® Study
Written by Customer Service on . Posted in Public Companies.
Company maintains confidence in ReNu as innovative pain management therapySecond Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpointStatistically significant maintenance of function (p
HF Foods Group Inc. Announces $100 Million At-The-Market (ATM) Equity Offering Program
Written by Customer Service on . Posted in Public Companies.
LAS VEGAS, Sept. 25, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading food distributor to Asian restaurants across the United States, announced today that it has established an At-The-Market (“ATM”) equity offering program under which it may sell, from time to time, shares of its common stock for aggregate gross proceeds of up to $100 million. The shares of common stock will be offered through D.A. Davidson & Co. and Roth Capital Partners, which will serve as sales agents for the ATM.
The Company intends to use the net proceeds from the sale of common stock under the ATM primarily for general corporate purposes, which may include, among other things, providing working capital, funding capital expenditures, and paying for possible acquisitions or the expansion of our business.
The...
